Impaired T lymphocyte function increases tumorigenicity and decreases tumor latency in a mouse model of head and neck cancer

International Journal of Oncology

Volumn 35, Issue 5, 2009, Pages 1211-1221

  Ku, Tony ^a   Crowe, David L ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Antibody; Carcinogenesis; Immunology; Metastasis; Squamous cell carcinoma

Indexed keywords

CYCLIN B; CYCLIN D;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL CYCLE REGULATION; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HEAD AND NECK CANCER; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; IMMUNOSURVEILLANCE; LATENT PERIOD; LYMPHOCYTE FUNCTION; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; UNINDEXED SEQUENCE; UPREGULATION;

ANIMALS; CARCINOMA, SQUAMOUS CELL; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GENE EXPRESSION PROFILING; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGIC SURVEILLANCE; MICE; MICE, NUDE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; T-LYMPHOCYTES;

EID: 70449590038     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000438     Document Type: Article

References (34)

1. Moore SR, Johnson NW, Pierce AM, et al: The epidemiology of mouth cancer: a review of global incidence. Oral Dis 6: 65-74, 2000. (Pubitemid 30159033)
2. Goldberg HI, Lockwood SA, Wyatt SW, et al: Trends and differentials in mortality from cancers of the oral cavity and pharynx in the United States. Cancer 74: 565-572, 1994.
3. Hernandez G, Arriba L, Jimenez C, et al: Rapid progression from oral leukoplakia to carcinoma in an immunosuppressed liver transplant recipient. Oral Oncol 39: 87-90, 2003. (Pubitemid 35379824)
4. King GN, Healy CM, Glover MT, et al: Increased prevalence of dysplastic and malignant lip lesions in renal transplant patients. N Eng J Med 332: 1052-1057, 1995.
5. De Visscher JG, Bouwes Bavinck JN and van der Waal I: Squamous cell carcinoma of the lower lip in renal transplant recipients. Int J Oral Maxillofac Surg 26: 120-123, 1997
6. Bilinska-Pietraszek E, Namyslowski G, Mrowka-Kata K, Scierski W and Aniol-Borkowska M: A case of tongue neoplasm in a 15 year old patient treated with immunosuppressants for renal insufficiency. Otolaryngol Pol 55: 95-97, 2001.
7. Van Zuuren EJ, De Visscher JG and Bouwes Bavinck JN: Carcinoma of the lip in kidney transplant recipients. J Am Acad Dermatol 38: 497-499, 1998. (Pubitemid 28125540)
8. Bhatia S, Louie AD, Bhatia R, et al: Solid cancers after bone marrow transplantation. J Clin Oncol 19: 464-471, 2001. (Pubitemid 32112860)
9. Jewett A, Head C and Cacalano NA: Emerging mechanisms of immunosuppression in oral cancers. J Dent Res 85: 1061-1073, 2006. (Pubitemid 44935523)
10. Dunn GP, Bruce AT, Ikeda H, Old LJ and Schreiber RD: Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 3: 991-998, 2002. (Pubitemid 35363648)
11. Dunn GP, Old LJ and Schreiber RD: The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21: 137-148, 2004.
12. Laad A, Kode J, Chavan S, Rao R, Fakih AR and Chiplunkar S: Limiting dilution analysis of proliferating and cytotoxic lymphocytes in the peripheral blood and tumors of oral cancer patients. Eur J Cancer 32: 337-342, 1996. (Pubitemid 26361666)
13. Jewett A, Cacalano NA, Head C and Teruel A: Coengagement of CD16 and CD94 receptors mediates secretion of chemokines and induces apoptotic death of native natural killer cells. Clin Cancer Res 12: 1994-2003, 2006.
14. Thomas DW, Matthews JB, Patel V, Game SM and Prime SS: Inflammatory cell infiltrate associated with primary and transplanted tumors in an inbred model of oral carcinogenesis. J Oral Pathol Med 24: 23-31, 1995.
15. Schantz SP, Shillitoe EJ, Brown B and Campbell B: Natural killer cell activity and head and neck cancer: a clinical assessment. J Natl Cancer Inst 77: 869-875, 1986. (Pubitemid 16031849)
16. Hoffmann TK, Donnenberg AD, Finkelstein SD, et al: Frequencies of tetramer+ T cells specific for the wild type sequence p53(264-272) peptide in the circulation of patients with head and neck cancer. Cancer Res 62: 3521-3529, 2002.
17. Whiteside TL, Letessier E, Hirabayashi H, et al: Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck. Cancer Res 53: 5654-5662, 1993. (Pubitemid 23360267)
18. Whiteside TL, Chikamatsu K, Nagashima S and Okada K: Antitumor effects of cytolytic T lymphocytes (CTL) and natural killer (NK) cells in head and neck cancer. Anticancer Res 16: 2357-2364, 1996. (Pubitemid 26325416)
19. Han X, Papadopoulos AJ, Ruparelia V, Devaja O and Raju KS: Tumor lymphocytes in patients with advanced ovarian cancer: changes during in vitro culture and implications for immunotherapy. Gynecol Oncol 65: 391-398, 1997.
20. + T lymphocytes and human squamous cell carcinoma of the head and neck. Cell Immunol 177: 35-48, 1997.
21. Marrogi AJ, Munshi A, Merogi AJ, et al: Study of tumor infiltrating lymphocytes and transforming growth factor beta as prognostic factors in breast carcinoma. Int J Cancer 74: 492-501, 1997. (Pubitemid 27486505)
22. Reichert TE, Strauss L, Wagner EM, Gooding W and Whiteside TL: Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor infiltrating lymphocytes in patients with oral carcinoma. Clin Cancer Res 8: 3137-3145, 2002. (Pubitemid 35155023)
23. Ku TKS, Nguyen DC, Karaman M, Gill P, Hacia JG and Crowe DL: Loss of p53 expression correlates with metastatic phenotype and transcriptional profile in a new mouse model of head and neck cancer. Mol Cancer Res 5: 351-362, 2007. (Pubitemid 46706997)
24. Nguyen DC, Parsa B, Close A, Magnusson B, Sinha U and Crowe DL: Overexpression of cell cycle regulatory proteins correlates with advanced tumor stage in head and neck squamous cell carcinomas. Int J Oncol 22: 1285-1290, 2003.
25. Andersen MH, Schrama D, Straten PT and Becker JC: Cytotoxic T cells. J Invest Dermatol 126: 32-41, 2006.
26. Gasser S and Raulet DH: The DNA damage response arouses the immune system. Cancer Res 66: 3959-3962, 2006.
27. Katou F, Ohtani H, Watanabe Y, Nakayama T, Yoshie O and Hashimoto K: Differing phenotypes between intraepithelial and stromal lymphocytes in early stage tongue cancer. Cancer Res 67: 11195-11201, 2007. (Pubitemid 350248544)
28. Willimsky G and Blankenstein T: Sporadic immunogenic tumors avoid destruction by inducing T cell tolerance. Nature 437: 141-146, 2005. (Pubitemid 41613441)
29. Kim R, Emi M, Tanabe K and Arihiro K: Tumor driven evolution of immunosuppressive networks during malignant progression. Cancer Res 66: 5527-5536, 2006. (Pubitemid 43927099)
30. Koebel CM, Vermi W, Swann JB, et al: Adaptive immunity maintains occult cancer in an equilibrium state. Nature 450: 903-908, 2007. (Pubitemid 350231320)
31. Renkvist N, Castelli C, Robbins PF and Parmiani G: A listing of human tumor antigens recognized by T cells. Cancer Immunol Immunother 50: 3-15, 2001. (Pubitemid 32250041)
32. Ciernik IF, Berzofsky JA and Carbone DP: Human lung cancer cells endogenously expressing mutant p53 process and present the mutant epitope and are lysed by mutant specific cytotoxic T lymphocytes. Clin Cancer Res 2: 877-882, 1996.
33. Castelli C, Rivoltini L, Andreola G, Carrabba M, Renkvist N and Parmiani G: T cell recognition of melanoma associated antigens. J Cell Physiol 182: 323-331, 2000.
34. Vonderheide RH, Hahn WC, Schultze JL and Nadler LM: The telomerase catalytic subunit is a widely expressed tumor associated antigen recognized by cytotoxic T lymphocytes. Immunity 10: 673-679, 1999.